I nd i a S te m C e lls Ma r ke t

Fo re ca s t & O p p o r t u ni t i e s , 2 0 2 0
Pharma & Healthcare Consultants

Industry Brief
India Stem Cells Market to Grow at 28% through 2020

Growing presence of stem cells research centres, increasing consumer awareness and rising medical tourism is
driving Indian stem cells market
According to recently published Pharmaion report, India Stem Cells Market Forecast & Opportunities,
2020, stem cells market in India is anticipated to grow at a CAGR of over 28% over 2015 - 2020. Growth in
the market is anticipated on account of increasing investments from the government as well as various private
organizations, growing industry focus on stem cell research, and rising awareness about stem cell banking.
Moreover, emergence of induced pluripotent stem (iPS) cells as an alternative to embryonic stem cells (ESCs),
and evolution of new stem cell therapies are anticipated to boost growth in stem cells market in India over the
next five years.
Being considered as the building blocks of life, stem cells are capable of treating various diseases, such as
diabetes, multiple sclerosis, Parkinson's, Alzheimer's, arthritis, blindness, stroke and heart diseases. Moreover,
scientists across the country are working on techniques to further enhance the efficacy of stem cell therapy. For
instance, menstrual stem cell technology is a budding trend, which is capable of growing heart muscles at a
success rate of more than 100 times higher than the 0.2-0.3% for stem cells taken from bone marrow. These
cells can revolutionise the way many diseases are being treated and transform the lives of millions of people
across the country in the coming years.
On the basis of services offered, India stem cells market has been segmented into two categories, namely, stem
cell banking and stem cell research. Stem cell research dominated the market in 2014, and is anticipated to
continue its dominance during 2015 - 2020 on account of growing focus on commercialization of public and
private research, rising number of stem cell research groups, and escalating cost for traditional drug
development. In 2014, adult stem cells accounted for a majority share in the India stem cells market owing to a
large number of research being carried out using adult stem cells.
Private stem cell banks are adopting various marketing tactics in order to increase their product visibility across
the country. Sales force of these private firms are visiting consumers and educating them about stem cell
banking concepts and associated advantages. Moreover, in India, the stem cell industry is witnessing increasing
level of collaborations among the various stakeholders, which is positively impacting the stem cells market in the
country. said Mr. Karan Chechi, Research Director with Pharmaion, a research based global pharmaceutical and
healthcare consulting firm.

2
Pharmaion

Ta b l e o f C o nt e nt s
S No.

Contents

1.

Research Methodology

2.

Analyst View

3.

Product Overview

4.

Global Stem Cell Market Overview

5.

India Stem Cell Market Outlook

5.1.

Market Size & Forecast

5.1.1.

5.2.

6.

Market Share & Forecast

5.2.1.

By Services

5.2.2.

By Type

5.2.3.

By Region

5.2.4.

By Ownership

India Stem Cell Research Market Outlook

6.1.

Market Size & Forecast

6.1.1.

6.2.

By Value

Market Share & Forecast

6.2.1.

7.

By Value

By Type

India Stem Cell Banking Market Outlook

7.1.

Market Size & Forecast

7.1.1.

7.2.

By Value

Market Share & Forecast

7.2.1.

By Type

3
Pharmaion

Ta b l e o f C o nt e nt s
S No.

8.

9.

Contents

Market Dynamics
8.1.

Drivers

8.2.

Challenges

Market Trends & Developments

9.1.

Medical Tourism

9.2.

Dental Stem Cell Banking

9.3.

Menstrual Blood Stem Cell Banking

9.4.

New Marketing Concepts

9.5.

Collaborations & Partnerships

10.

SWOT Analysis

11.

Policy & Regulatory Landscape

12.

India Economic Profile

13.

Competition Landscape
13.1.

Competition Matrix

13.2.

Company Profiles
13.2.1.

LifeCell International Pvt. Ltd

13.2.2.

Reliance Life Sciences Pvt. Ltd.

13.2.3.

Cryobanks International India Pvt. Ltd.

13.2.4.

CordLife Sciences India Pvt. Ltd.

13.2.5.

Cryo-Save (India) Private Limited

13.2.6.

Stemade Biotech Pvt. Ltd.

13.2.7.

Institute for Stem Cell Biology and Regenerative Medicine (inStem)

4
Pharmaion

Ta b l e o f C o nt e nt s
S No.

Contents
13.2.8.

Nichi-In Centre for Regenerative Medicine

13.2.9.

TranScell Biologics Pvt. Ltd.

13.2.10.

EmProCell Clinical Research Private Limited

14.

Strategic Recommendations

15.

About Us & Disclaimer

5
Pharmaion

Research Methodology
Baseline Methodology:

For the study, Pharmaion has gathered information through primary research with respondents in stem cell banking
and research companies across India, followed by external validation of the information by interview ing

distributors. We also gathered insights through exhaustive search of credible paid databases and our internal
database. Our team of analysts has then prudently evaluated all the collected information and presented it in
chronological order to depict a meaningful and comprehensible picture of India stem cells market.

While compiling the data, we have also validated all the collected information from multiple sources and data
warehouses, in order to present accurate and precise information of the concerned industry. The same information

has then been verified through primary research surveys with competitors to arrive at logical figures.

Manufacturers Interviewed
Nichi-In Centre for Regenerative Medicine, LifeCell International Pvt. Ltd., Reliance Life Sciences Pvt. Ltd., L V
Prasad Eye Institute, inStem, Cryobanks International India Pvt. Ltd., EmProCell Clinical Research Private Limited,
TranScell Biologics PVT.,LTD.

Sources: Company Websites, The National Apex Committee for Stem Cell Research and Therapy (NAC-SCRT),
Indian Council of Medical Research (ICMR) and Department of Biotechnology (DBT)

6
Pharmaion

Sample Data - Snapshot

India Stem Cells Banking Market Size, By

India Stem Cells Market Share, By Region, By Value, 2010-2020F

3 3 .1 0%3 3 .2 0%3 3 .3 0%3 3 .4 0%3 3 .5 0%3 3 .6 0%3 3 .7 0%3 3 .8 0%3 3 .9 0%3 4 .0 0%
3 3 .0 0%
South

3 0 .1 0%3 0 .2 0%3 0 .3 0%3 0 .4 0%3 0 .5 0%3 0 .6 0%3 0 .7 0%3 0 .8 0%3 0 .9 0%3 1 .0 0%

3 0 .0 0%

Value, 2010-2020F (USD Million)

19
17
15
13
9
7

21

23

West

2010 2011 2012 2013 2014

2 8 .1 0%2 8 .2 0%2 8 .3 0%2 8 .4 0%2 8 .5 0%2 8 .6 0%2 8 .7 0%2 8 .8 0%2 8 .9 0%2 9 .0 0%

2 8 .0 0%

North

2015E 2016F 2017F 2018F 2019F 2020F

India Summary of Diabetes Indicators, 2014

3 .0 0 % 3 .1 0 % 3 .2 0 % 3 .3 0 % 3 .4 0 % 3 .5 0 % 3 .6 0 % 3 .7 0 % 3 .8 0 % 3 .9 0 % 4 .0 0 %

2010

2011

2012

2013

2014

2015E 2016F 2017F 2018F 2019F 2020F

Indicators

India

Diabetes cases X (million)

Others

Average Cost of Stem Cell Banking

India Adult Stem Cells Market
Share, By Type, By Value, 2014
Pancreatic
Progenitor
Cells, 10%
Muscle,
10%

Hematopoietic &
Bone Marrow,
10%

Retinal, 10%
Cardiac, 10%

Limbal, 10%

Cancer, 10%
Mesenchymal,
10%
Neuronal,
10%

Liver,
10%
India Stem Cells Market Size, By

Value, 2010-2020F (USD Million)

17
15
13
9
7
5
3

2010 2011 2012 2013 2014

Undiagnosed diabetes cases X

in India (USD)

(million)

Cord Stem Cell

Banking

Dental Stem Cell

Banking

Bone Marrow Stem

Cell Banking

(X%)

Menstrual Blood
Stem Cell Banking

Diabetes related deaths X (million)

Adipose Tissue Stem

Cell Banking

Cost/person with diabetes (X)

Diabetes national prevalence (X%)

Diabetes comparative prevalence

X
X

India Stem Cells Market Share, By Service, By Value, 2010-2020F

19

21

23

6 0 .1 0%6 0 .2 0%6 0 .3 0%6 0 .4 0%6 0 .5 0%6 0 .6 0%6 0 .7 0%6 0 .8 0%6 0 .9 0%6 1 .0 0%

6 0 .0 0%

3 8 .1 0%3 8 .2 0%3 8 .3 0%3 8 .4 0%3 8 .5 0%3 8 .6 0%3 8 .7 0%3 8 .8 0%3 8 .9 0%3 9 .0 0%

3 8 .0 0%

7
2015E2016F2017F2018F2019F2020F

2010

2011

2012

2013

2014

Stem Cell Banking

2015E 2016F 2017F 2018F 2019F 2020F

Stem Cell Research

Pharmaion

Report Ordering

Report Name: India Stem Cells Market Forecast and

Opportunities, 2020

Report Price

License Type

Price

Single User License

$3000

Single User License Print

$3500

Enterprise License

$6000

To View Sample OR Purchase Report

8
Pharmaion

About Us & Disclaimer

About Us :
Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry.
Pharmaions core values are value, integrity and insight. Led by a team of dynamic industry experts, Pharmaion provides its customers
with high value market research and advisory services that helps them identify new market opportunities, growth engines and
innovative ways to capture the market share. As a result, Pharmaions clients lead rather than follow market trends. Not bound by
legacy, Pharmaions cutting-edge research model leverages its decades of research knowledge and an increased use of technology as
engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, Pharmaions reports
do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.
Pharmaion is committed to assisting customers worldwide with their unique market research needs by providing them with
comprehensive, value-added solutions and professional market intelligence services. Pharmaion employs the industrys best-trained
industry Analysts and Consultants, which advises and assists customers in meeting their full service market research and consulting
requirements.

Related Reports
India Hospitals Market Forecast & Opportunities, 2020
Global Tissue Engineered Medical Devices Market Forecast & Opportunities, 2020
Global Cervical Cancer Vaccine Market Forecast & Opportunities, 2020

Disclaimer :
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made
that it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has been obtained from
various sources including which it considers reliable and first hand. However, Pharmaion Consultants does not guarantee the accuracy, adequacy or
completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and
especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates
and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for clients
internal consumption. Usage of the same for purpose other than internal will require prior approval of Pharmaion Consultants.

NORTH AMERICA
Pharmaion Consultants LLC
708 3RD Avenue, 6th Floor, New York, NY,
United State, 10017
sales@pharmaion.com
+1 646 360 1656
www.pharmaion.com

ASIA-PACIFIC
Pharmaion Consultants Pvt. Ltd.
A 51, Sector 57, Noida, National Capital Region,
India - 201301
sales@pharmaion.com
+91 - 120 - 452 3900
www.pharmaion.com

9
Pharmaion